Egypt Oncology Market Analysis


  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Egypt
  • Report ID : 4774

  • Format: PPT, PDF

Egypt Oncology Drug Market: Segmentation by Disease Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Other Cancers), Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), Route of Administration ( Oral, Parenteral and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End Users (Hospitals, Homecare, Specialty Clinics, and others) – Growth, Trends, And Forecasts (2019 – 2028)

 Published Date: June, 2021

SKU: 4774 Categories: ,

Egypt’s Oncology drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

In Egypt, noncommunicable diseases are responsible for 85% of deaths, with cancers representing the second most common cause of mortality (14%) after cardiovascular diseases (46%). It has an ambitious plan for preventing and controlling non-communicable diseases, including cancer, which was initiated in 2018 (known as the Egypt National Multisectoral Action Plan for Prevention and Control of Noncommunicable Diseases).

In 2020, there were about 134642 new cancer cases and 89,042 cancer-related deaths in Egypt. Liver and breast cancers are the most common tumors in terms of incidence and mortality.

Patients with cancer in Egypt receive their treatment in General Authority for Health Insurance hospitals, in Ministry of Health and Population or university hospitals at the government’s expense, or in the private sector at their own expense or with personal insurance coverage.

Market Drivers

The estimated trends for breast and lung cancer in Egypt are projected to rise in the future. According to World Health Organization’s Egypt’s profile for cancer, the breast cancer cases might go up to 40, 544 by 2040 as compared to the 23,081 cases in 2018. For Lung cancer this figure might go up to 11, 945 cases by 2040 as compared to the 6,045 reported cases in 2018.

Such a rise in the prevalence of cancer among the population is likely to drive the market growth for Oncology Therapeutics in Egypt.

Further, the introduction of the Universal Health Insurance Law by the government in 2018 will see an increase in the number of health institutions and facilities, as the government pledges to take care of non-communicable diseases including cancer which has been a major part of the existing disease burden in Egypt. Such initiatives are forecasted to be a positive growth sign for the oncology therapeutics market in the country.

1. Oncology Drug Market Overview………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rise in incidence of cancer cases in Egypt
B. Government’s commitment to reducing disease burden
3. Major Types of Treatment
A. Surgery
B. Immunotherapy
C. Radiation therapy
D. Chemotherapy
E. Targeted Therapy
F. Hormone therapy
G. Stem cell transplant
H. Biomarker testing
4. Oncology Drug Market Segmentation…………………………………
A. Disease Indication
I. Lung Cancer
II. Stomach Cancer
III. Colorectal Cancer
IV. Breast Cancer
V. Prostate Cancer
VI. Liver Cancer
VII. Esophagus Cancer
VIII. Cervical Cancer
IX. Kidney Cancer
X. Bladder Cancer
XI. Other Cancers
B. Drug Class
I. Chemotherapy
II. Targeted Therapy
III. Immunotherapy (Biologic Therapy)
IV. Hormonal Therapy
C. Route of Administration
I. Oral
II. Parenteral
III. Others
D. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
E. End-User
I. Hospitals
II. Home-cares
III. Speciality Units
IV. Others
5. Oncology Disease Major Drugs Market Share………………………………..
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Boehringer Ingelheim overview, Product & Services, Strategies & Financials
B. AstraZeneca. Company overview, Product & Services, Strategies & Financials
C. GSK Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………….
A. New Trends and Development of Oncology disease drug market
B. Future Opportunities
10. Conclusion

By Disease Indication

The market for the treatment of Oncology disease can be segmented into Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Other Cancers

By Drug Class

By drug class, the market can be segmented into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy

By Route of Administration

Based on route of administration the anti-cancer drug market is segmented into oral, parenteral, and others

By Distribution Channel

By distribution channel, the market for oncology drugs in Egypt can be segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

By End-user

On the basis of end-users, the anti-cancer drug market is segmented into hospitals, home care, specialty clinics, and others

Major Players

Egypt’s Oncology diseases drug market boasts of leading global companies such as including Boehringer Ingelheim, AstraZeneca, Novartis, GSK, Sanofi, Pharco, Pfizer, Hikma.

Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, signed a three-way agreement with a local Egyptian pharmaceutical company called Egy Drug Company and Poly Pharm in 2019 to effectively regulate commercial ties and ensure access to innovative drugs in Egypt. The agreement also aims at diversifying Boehringer Ingelheim’s distributors base locally.

Pfizer operates in Egypt through its 100% owned subsidiary Pfizer Egypt. The company currently has around 70 drugs on the Egyptian market and seeks to introduce six additional innovative products for the treatment of breast cancer, blood thinning, and tumors

AstraZeneca Egypt has launched affordability programs for diabetes and oncology products aiming at increasing patients’ access to innovative medicines, decreasing patients’ burden, and improving adherence/ compliance to medicines. Due to the increasing importance of oncology, they are planning to launch four products in this treatment area in the next few years, including Lynparza and Imfinzi.

Further, Elekta, a leader in precision radiation medicine, announced that it will establish a permanent office in Cairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements